New drug duo shows promise against incurable lymphoma
NCT ID NCT06112847
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 25 times
Summary
This study tests whether combining two drugs—lenalidomide and epcoritamab—can better control follicular lymphoma that hasn't been treated yet. Follicular lymphoma is not curable, but this combination aims to boost the immune system to kill cancer cells more effectively. About 29 adults with the disease will receive the treatment to see how many achieve a complete response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOLLICULAR LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
-
City of Hope at Irvine Lennar
Irvine, California, 92618, United States
Conditions
Explore the condition pages connected to this study.